申请人:Namboothiri Irishi N.N.
公开号:US20110160276A1
公开(公告)日:2011-06-30
A compound has Formula VIII where, X is —C(O)R, —C(O)OR, —CN, —NO
2
, —S(O)
2
R′, —P(O)(OR)
2
; each R is individually H, alkyl, or alkenyl; R′ is alkyl or akenyl; R
1
is aryl, alkenyl, arylalkenyl, heterocyclyl, or heteroaryl; and R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, and R
11
are individually H, alkoxy, or hydroxy. In some cases, X is NO
2
.
Pharmaceutical compositions of the compound of Formula VIII with a pharmaceutically acceptable carrier may be prepared. The compounds may be used for inhibition of cyclooxygenase-2.
该化合物的化学式为VIII,其中X为—C(O)R、—C(O)OR、—CN、—NO2、—S(O)2R′、—P(O)(OR)2;每个R分别为H、烷基或烯基;R′为烷基或烯基;R1为芳基、烯基、芳基烯基、杂环烷基或杂环芳基;R2、R3、R4、R5、R6、R7、R8、R9、R10和R11分别为H、烷氧基或羟基。在某些情况下,X为NO2。可以制备该化合物的药物组合物,与药物可接受载体混合。该化合物可用于抑制环氧化酶-2。